Trained immunity is an emerging field that describes the innate immune system’s ability to develop memory-like characteristics following exposure to ...
Malaysia has long established TB control programmes that include vaccination, screening and access to effective treatment. With proper medical management, most patients with TB can recover fully and ...
By doubling its production of blue foods, such as fish, shellfish, crustaceans, and aquatic plants, Africa could reduce its ...
ImmunityBio (NASDAQ: IBRX) recently announced a partnership with Accord Healthcare to expand European access to ANKTIVA for bladder cancer patients across 33 countries. ANKTIVA achieved a 71% complete ...
ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.
A 91-year-old man with a history of bladder carcinoma and left total knee arthroplasty was evaluated because of left knee pain. A culture of synovial fluid showed no growth. A diagnosis was made.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results